Avid Bioservices Inc (CDMO)

[PPHMVERYLONG]

"One other point of interest, in view of the very advanced development stage Bavituximab has reached, the highly negative opinion we see at this time is puzzling. Why?"


The answer is obvious. All this might be true but the market thinks these things do not make the drug more likely to succeed. We still have no major trials where it succeeded(botched trial does not count). And since no cash deal, W.S. believes the biotech community does not think the data compelling or a partnership would have happened long ago. That is why a cash partnership was essential and since it will not happen until positive Phase III data is realized if ever, we are dead for the time being. Remember I said, nothing for 2015. And since we are moving into the 4th qtr., you must admit I will probably be correct.